Dr. Reddy's Laboratories Limited

NYSE:RDY Stock Report

Market Cap: US$12.6b

Dr. Reddy's Laboratories Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Erez Israeli

Chief executive officer

₹195.4m

Total compensation

CEO salary percentagen/a
CEO tenure6yrs
CEO ownership0.02%
Management average tenure6yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

Dr. Reddy's Laboratories: Q2 Earnings Reveals Strong Growth And Promising Advancements

Nov 29

Dr. Reddy's: Continued Q2 Earnings Growth, Supports Long-Term Investment Outlook

Oct 27

Dr. Reddy's: Growth Supported By New Labels, Profitability

Aug 23

Dr. Reddy's Laboratories: Unpacking The Critical Factors, Reiterate Buy

Jun 07

Dr. Reddy's Laboratories: Positive Q3 Results, Growth Supportive Of Buy

Feb 16

Dr. Reddy's prepare to file for Rituxan biosimilar in US, EU as trials completed

Jan 20

Dr. Reddy's Needs Time For Generics Sales To Replace Sputnik Revenue

Nov 07

Dr. Reddy's GAAP EPS of $0.90, revenue of $660M misses by $12.78M

Jul 28

Dr. Reddy's launches generic drugs for allergies in US

Jul 22

Dr. Reddy's, EQRx team up to develop drugs for cancer, immune-inflammatory diseases

Jul 05

Dr. Reddy's in talks to bring single-dose Sputnik Light vaccine in India

May 31

CEO Compensation Analysis

How has Erez Israeli's remuneration changed compared to Dr. Reddy's Laboratories's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

₹52b

Sep 30 2023n/an/a

₹51b

Jun 30 2023n/an/a

₹47b

Mar 31 2023₹195mn/a

₹45b

Dec 31 2022n/an/a

₹36b

Sep 30 2022n/an/a

₹31b

Jun 30 2022n/an/a

₹30b

Mar 31 2022₹127mn/a

₹24b

Dec 31 2021n/an/a

₹26b

Sep 30 2021n/an/a

₹19b

Jun 30 2021n/an/a

₹17b

Mar 31 2021₹120mn/a

₹17b

Dec 31 2020n/an/a

₹21b

Sep 30 2020n/an/a

₹15b

Jun 30 2020n/an/a

₹19b

Mar 31 2020₹195m₹107m

₹19b

Dec 31 2019n/an/a

₹16b

Sep 30 2019n/an/a

₹27b

Jun 30 2019n/an/a

₹21b

Mar 31 2019₹123mn/a

₹19b

Compensation vs Market: Erez's total compensation ($USD2.34M) is below average for companies of similar size in the US market ($USD13.52M).

Compensation vs Earnings: Erez's compensation has increased by more than 20% in the past year.

CEO

Erez Israeli (55 yo)

6yrs

Tenure

₹195,380,000

Compensation

Mr. Erez Israeli, MBA has been Chief Executive Officer of Dr. Reddy's Laboratories Limited since August 1, 2019. Mr. Israeli served as Chief Operating Officer, Global Head Generics & PSAI Business and Memb...

Leadership Team

NamePositionTenureCompensationOwnership
Gunupati Prasad
Co-Chairman38yrs₹187.71m1.54%
₹ 193.3m
Kallam Reddy
Chairman of the Board & Member of the Management Council31.3yrs₹115.40m4.53%
₹ 569.5m
Erez Israeli
CEO & Member of the Management Council6yrs₹195.38m0.022%
₹ 2.8m
Parag Agarwal
CFO & Member of Management Council3.3yrs₹65.16mno data
Deepak Sapra
CEO of API & Services & Member of Management Councilno data₹40.12mno data
Venkata Motupalli
CEO of Branded Markets - India & Emerging Countries and Member of Management Councilno data₹80.20mno data
Archana Bhaskar
EVP, Head of Corporate Communications6.8yrs₹63.42mno data
Sanjay Sharma
Executive VP6.7yrs₹61.42mno data
Marc Kikuchi
CEO of North America Generics & Member of Management Council5.2yrs₹112.49m0.016%
₹ 2.0m
Patrick Aghanian
CEO of European Generics & Member of Management Councilno data₹91.63mno data
Mannam Venkatanarasimham
Deputy CFO & Member of the Management Councilno data₹47.20mno data
Sushrut Kulkarni
Global Head of Integrated Product Development Organisation & Member of the Management Councilno data₹48.35mno data

6.0yrs

Average Tenure

55.5yo

Average Age

Experienced Management: RDY's management team is seasoned and experienced (6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Gunupati Prasad
Co-Chairman38yrs₹187.71m1.54%
₹ 193.3m
Kallam Reddy
Chairman of the Board & Member of the Management Council31.3yrs₹115.40m4.53%
₹ 569.5m
Kalpana Morparia
Lead Independent Director16.8yrs₹15.35m0.0065%
₹ 815.1k
R. Rajgopalan
Member of the Scientific Advisory Boardno data₹8.36mno data
Arun Kumar
Independent Director1.7yrs₹10.95mno data
Shikha Sharma
Additional Independent Director5.3yrs₹13.15mno data
K. Reddy
Member of the Scientific Advisory Boardno datano datano data
Leo Puri
Independent & Non Whole-time Director5.5yrs₹15.30mno data
Kodumudi Krishnan
Additional Independent Director2.3yrs₹3.41mno data
Alpna Seth
Independent Director1.3yrsno datano data
Penny Wan
Additional Independent Director2.3yrs₹16.84mno data
Claudio Albrecht
Directorless than a yearno datano data

3.8yrs

Average Tenure

63yo

Average Age

Experienced Board: RDY's board of directors are considered experienced (3.8 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.